Michael Petusky

Stock Analyst at Barrington

(2.37)
# 2,988
Out of 4,574 analysts
642
Total ratings
43.8%
Success rate
0.6%
Average return

Stocks Rated by Michael Petusky

Orthofix Medical
Jul 17, 2026
Maintained: Buy
Price Target: $17
Current: $11.25
Upside: +51.11%
Merit Medical Systems
Jul 14, 2026
Reiterated: Buy
Price Target: $107
Current: $74.32
Upside: +43.97%
Bioventus
Jul 6, 2026
Maintained: Buy
Price Target: $14
Current: $11.80
Upside: +18.64%
Lifecore Biomedical
Jun 16, 2026
Maintained: Buy
Price Target: $6$6.5
Current: $4.33
Upside: +50.12%
LeMaitre Vascular
Jun 3, 2026
Maintained: Buy
Price Target: $120
Current: $95.59
Upside: +25.54%
U.S. Physical Therapy
May 13, 2026
Maintained: Buy
Price Target: $103$90
Current: $74.58
Upside: +20.68%
Haemonetics
May 12, 2026
Maintained: Buy
Price Target: $94$89
Current: $78.78
Upside: +12.97%
DENTSPLY SIRONA
May 6, 2026
Maintained: Buy
Price Target: $17
Current: $12.93
Upside: +31.48%
Henry Schein
May 6, 2026
Maintained: Buy
Price Target: $97
Current: $85.47
Upside: +13.49%
Option Care Health
May 1, 2026
Maintained: Buy
Price Target: $42$32
Current: $21.66
Upside: +47.74%
Maintained: Buy
Price Target: $17
Current: $14.95
Upside: +13.71%
Downgraded: Hold
Price Target: n/a
Current: $1.22
Upside: -
Maintained: Buy
Price Target: $1$1.5
Current: $0.65
Upside: +130.77%
Downgraded: Hold
Price Target: n/a
Current: $0.015
Upside: n/a
Initiated Coverage: Buy
Price Target: n/a
Current: $41.30
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Upgraded: Buy
Price Target: $30
Current: $25.82
Upside: n/a
Rated: Buy
Price Target: $6.5
Current: $1.01
Upside: n/a